Why Globe Life Inc. (GL) Stock Fell 8.1% on Oct 23, 2026
What happened
Globe Life Inc. shares fell 5.44% to $159.25 following a Piper Sandler downgrade to Neutral with a $165.00 price target, citing reduced confidence in predictability and health segment exposure (Seeking Alpha, Investing.com). The downgrade came after Q3 earnings missed consensus—Globe Life reported $4.84 EPS versus $4.91 expected—and the company cut full-year guidance to $15.35–$15.65 per share due to underwriting losses at Evry Health and excess Medicare Supplement claims from CMS processing delays. Volume was elevated at 2.42x the time-adjusted expected level.
GL earnings scheduled for 2026-10-28; watch for any management commentary on claims normalization and Evry Health turnaround plans, and monitor whether consensus EPS estimates ($4.91) are revised lower in the coming sessions.
Other developments that session
GL reported Q3 2026 net income of $361M ($4.62/share, down 2%) while operating income rose 1% to $4.84/share.
Frequently asked questions
Why did Globe Life Inc. (GL) stock fall on Oct 23, 2026?
Globe Life Inc. shares fell 5.44% to $159.25 following a Piper Sandler downgrade to Neutral with a $165.00 price target, citing reduced confidence in predictability and health segment exposure (Seeking Alpha, Investing.com). The downgrade came after Q3 earnings missed consensus—Globe Life reported $4.84 EPS versus $4.91 expected—and the company cut full-year guidance to $15.35–$15.65 per share due to underwriting losses at Evry Health and excess Medicare Supplement claims from CMS processing delays. Volume was elevated at 2.42x the time-adjusted expected level.
How much did GL stock fall on Oct 23, 2026?
GL fell 8.1% during the Oct 23, 2026 trading session.